Back to results
US 5,328,829 AGranted
Method of determining sites of active periodontal disease
AssigneeForsyth Dental Infirmary for Children
InventorPhilip Stashenko
Life of this patent
Estimating the term…
Abstract
The present invention comprises a method for the determination of periodontal disease active sites within the human oral cavity by a measurement of the level of interleukin 1 beta (IL-1b) in oral tissues and gingival crevicular fluid at a particular site.
Claims9
A method for the determination of periodontal disease active sites in the oral cavity of a patient, which method comprises:
- a) determining the concentration of interleukin 1 beta (IL-1b) of a sample taken from a site in the oral cavity;
- and
- (b) identifying the site as an active periodontal disease site when the concentration of interleukin 1 beta (IL-1b) is greater than about 25 ng/ml.
A method for the determination of periodontal disease active sites in the oral cavity of a patient, which method comprises:
- a) obtaining a sample of gingival tissue or gingival crevicular fluid from a selected periodontal site in the oral cavity of a patient;
- b) determining the concentration of interleukin 1 beta (IL-1b) of the sample;
- and
- c) identifying the site as an active periodontal disease site where the concentration of interleukin 1 beta (IL-1b) determined is greater than about 25 ng/ml.
1 more element
Dependencies are inferred from the claim text.